低负荷加压抗阻训练对比高负荷抗阻训练治疗社区老年人肌少症的三臂随机对照试验方案
主要结局为下肢肌力,次要结局涵盖体成分、上肢肌力、肺功能、血液生物标志物、心血管疾病危险因素及生活质量。
要点
- LRT-BFR可能以较小负荷获得与CRT相似的肌力和肌肉量增益。
- 主要结局为下肢肌力,随访至第24周。
- 纳入标准依据AWGS肌少症诊断标准。
核心结论
- 本研究为方案,尚未报告疗效与安全性结果。
- 研究旨在比较LRT-BFR与CRT对社区老年肌少症患者的疗效与安全性。
研究设计与样本
- 12周、评估者盲法、三臂随机对照试验,设非运动对照组。
- 随机分为LRT-BFR组(n=17)、CRT组(n=17)和无力量训练对照组(n=17)。
- 在基线(0周)、干预12周后及随访(24周)评估指标,并按意向性治疗分析。
关键数值与推荐
- 主要结局为下肢肌力。
- 次要结局包括体成分、上肢肌力、肺功能、血液生物标志物、心血管疾病危险因素和生活质量。
- 干预后随访12周。
- 试验注册号:ChiCTR2100042803,注册日期2021年1月28日。
临床怎么用
- 目前仅为研究方案,尚不能据此改变临床实践。
- 若结果支持,LRT-BFR或可为老年肌少症患者提供省力的训练选择。
局限性
- 原文为研究方案,尚无疗效与安全性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sarcopenia is accompanied by a decline in muscle mass, muscle strength, and muscle function. Resistance training is the most potential training method for the prevention and treatment of sarcopenia. However, the conventional high-load resistance training (CRT) recommended by the American College of Sports Medicine is a challenge for older people with sarcopenia. As a novel training method, low-load resistance training combined with blood flow restriction (LRT-BFR) may elicit similar muscle mass and muscle strength gains as CRT but with less effort. The objectives of this study are to assess and compare the efficacy and safety of 12-week LRT-BFR and CRT on muscle strength, muscle performance, body composition, pulmonary function, blood biomarkers, CVD risk factors, and quality of life in community-dwelling older Chinese people with sarcopenia. METHOD: This is a 12-week, assessor-blinded, 3-arm randomized controlled trial with a non-exercise control group. Community-dwelling people over 65 years will be screened for sarcopenia according to the diagnostic criteria of the Asian Working Group for Sarcopenia (AWGS). Fifty-one subjects will be randomized into a LRT-BFR group (n = 17), a CRT group (n = 17), and a no-strength training control group (n = 17). The primary outcome is lower limb muscle strength. The secondary outcomes are body composition, upper limb muscle strength, pulmonary function, blood biomarkers, CVD risk factors, and quality of life. Post-intervention follow-up will be performed for 12 weeks. These indicators will be assessed at baseline (0 week), after the 12-week intervention (12 weeks), and at follow-up (24 weeks). The adverse events will also be reported. Data will be analyzed for all participants in an intent-to-treat plan. DISCUSSION: This study is the first RCT that will systematically measure and compare the efficacy and safety of LRT-BFR and CRT in older people with sarcopenia on muscle strength, body composition, pulmonary function, blood biomarkers (inflammatory biomarkers, hormone, and growth factors), CVD risk factors, and quality of life. This study can provide an efficient and safe method to prevent the progression of sarcopenia in older people. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2100042803 . Registered on 28 January 2021.
引用
- Chen N, He X, Zhao G, et al. Efficacy of low-load resistance training combined with blood flow restriction vs. high-load resistance training on sarcopenia among community-dwelling older Chinese people: study protocol for a 3-arm randomized controlled trial. Trials. 2021. PMID: 34348792. doi:10.1186/s13063-021-05495-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。